Lucchesi Maurizio

CURRICULUM VITAE
INFORMAZIONI PERSONALI
Nome:
data di nascita:
Specializzazione:
Attuale posizione lavorativa:
Telefono:
Fax:
E-mail:
ISTRUZIONE E FORMAZIONE
Maurizio Lucchesi Luogo e
06 Marzo 1984 Qualifica:
Medico Chirurgo
Oncologia Medica
Azienda Ospedaliero-Universitaria Meyer
Clinica Pediatrica I
Servizio di Neuro-Oncologia
+39 055 5662632
+39 055 5662746
[email protected]
ESPERIENZA LAVORATIVA
Università di Pisa
Scuola di Specializzazione in Oncologia Medica
AOUP – U.O. Oncologia Medica 2 Universitaria
AOUP – U.O. Oncologia Medica 1 SSN
Attività formativa-assistenziale su degenza, day hospital, ambulatori (patologie di riferimento: neoplasie toraciche e
geastrointestinali). Focus su terapie di supporto, degenza internistico-oncologica, gestione delle tossicità da trattamenti
anti-tumorale, e delle complicanze da malattia neoplastica (ambulatoriali e in regime di ricovero). Procedure interventistiche
(principalmente eco-guidate)*. Attività di ricerca.
*: dal 12 Giugno 2014 con autorizzazione aziendale all’utilizzo in autonomia delle apparecchiature ecografiche di reparto.
Dal 17 Maggio
2010 al 17 Maggio
2015
AOUP – U.O. Pneumologia 2 SSN (da 09/2014 confluita nella U.O. Pneumologia
Universitaria) – Servizio Pneumo-Oncologia – da Settembre 2013 a Gennaio 2015
(minimo 40 ore mensili)
Attività formativa-assistenziale su day hospital e ambulatori (neoplasie toraciche). Procedure interventistiche
(principalmente eco-guidate)*.
*: dal 12 Giugno 2014 con autorizzazione aziendale all’utilizzo in autonomia delle apparecchiature ecografiche di reparto.
AOUP – vincitore incarico per attività di supporto libero professionale intramoenia ex art
15 septies comma 5 bis DL 502/92 – 26 Agosto 2014
Selezione su base curriculare per esperienza nell’organizzazione del percorso assistenziale del paziente oncologico.
Istituto Nazionale dei Tumori di Milano – U.O. Pediatria Oncologica – dal 10 Novembre al
19 Dicembre 2014
Attività formativa-assistenziale su tumori solidi dell’età pediatrica
AOU Meyer Firenze – U.O. Neuro-Oncologia – dal Gennaio 2015 a Maggio 2015
Attività formativa-assistenziale su tumori solidi encefalici dell’età pediatrica
Dal 27 Maggio
2015 ad oggi
Azienda Ospedaliero-Universitaria Meyer
Clinica Pediatrica I – Servizio di Neuro-Oncologia
Incarico Libero Professionale come Medico Specialista
ALTRE ATTIVITA’
Pregressa attività di volontariato e vice-direzione in associazioni di soccorso e assistenza (2006-2007).
Pregressa attività di medico sostituto per servizio di continuità assistenziale SSN (2010).
COMPETENZE LINGUISTICHE
Italiano: madrelingua
Inglese: buona conoscenza (comprensione, scritto, e parlato)
SOCIETA’ SCIENTIFICHE
ASCO (American Society of Clinical Oncology)
ESMO (European Society of Medical Oncology)
MASCC (Multinational Association of Supportive Care in Cancer)
SIUMB (Società Italiana di Ultrasonologia in Medicina e Biologia)
NICSO (Network Italiano Cure di Supporto in Oncologia)
Membro
Membro
Membro
Membro
Membro con incarico istituzionale
(Referente Medico del Sito Internet)
PUBBLICAZIONI SCIENTIFICHE (lavori in extenso)
Second-line treatment for non-small-cell lung cancer: one size does not fit all.
Caponi S, Vasile E, Ginocchi L, Tibaldi C, Borghi F, D'Incecco A, Lucchesi M, Caparello C, Andreuccetti M,
Falcone A.
Clin Lung Cancer. 2010 Sep 1;11(5):320-7.
Docetaxel come trattamento di seconda linea in pazienti con carcinoma gastrico avanzato.
Lucchesi M, Fornaro L, Vasile E, Falcone A, Masi G.
Scenari. On line pub. 2010 Dec 16.
Anti-HER agents in gastric cancer: from bench to bedside.
Fornaro L, Lucchesi M, Caparello C, Vasile E, Caponi S, Ginocchi L, Masi G, Falcone A.
Nat Rev Gastroenterol Hepatol. 2011 Jun 7;8(7):369-83.
Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with
combination chemotherapy.
Giovannetti E, Pacetti P, Reni M, Leon LG, Mambrini A, Vasile E, Ghidini M, Funel N, Lucchesi M, Cereda S,
Peters GJ, Cantore M.
Pharmacogenomics. 2011 Dec;12(12):1641-52.
Supportive care and not only palliative care in the route of cancer patients.
Antonuzzo A, Lucchesi M, Brunetti IM, Galli L, Vasile E, Bonci F, Ricci S, Falcone A.
Support Care Cancer. 2013 Mar;21(3):657-8.
Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms.
Caponi S, Vasile E, Funel N, De Lio N, Campani D, Ginocchi L, Lucchesi M, Caparello C, Lencioni M, Cappelli
C, Costa F, Pollina L, Ricci S, Mosca F, Falcone A, Boggi U.
Eur J Surg Oncol. 2013 Apr;39(4):396-403.
La gestione dei sintomi. (In: La Medicina Oncologica.)
Ripamonti CI, Pessi MA, Lucchesi M, Rondelli P, Antonuzzo A.
Edra Editore. 2013 Capitolo 25; 897-957.
Not only chemotherapy in the second-line treatment of metastatic gastric cancer.
Vasile E, Caparello C, Caponi S, Ginocchi L, Vivaldi C, Musettini G, Lucchesi M, Lencioni M, Falcone A.
Ann Oncol. 2014 Feb;25(2):544-5.
Dedicated supportive care team at the oncology unit: a model of simultaneous care for cancer patients.
Vasile E, Lucchesi M, Ginocchi L, Brunetti IM, Galli L, Ricci S, Falcone A, Antonuzzo A.
Support Care Cancer. 2014 Apr;22(4):867-8.
The use of anthracyclines for therapy of CNS tumors.
Da Ros M, Iorio AL, Lucchesi M, Stival A, De Martino M, Sardi I.
Anticancer Agents Med Chem 2015 Apr;7 (on print)
PUBBLICAZIONI SCIENTIFICHE (abstract congressuali)
Prognostic relevance of lymph node metastases and adjuvant treatment for patients with invasive intraductal
papillary mucinous (IPMNs) of the pancreas. S. Caponi, E. Vasile, M. Del Chiaro, N. Funel, A. Sainato, V.
Perrone, C. Croce, M. Coppola, F. Pasqualetti, M. Lucchesi, L. Pollina, L. Cionini, D. Campani, A. Falcone, F.
Mosca, U. Boggi, Proceedings 11th National Congress of Medical Oncology (AIOM), Milan, Italy, October 10-13,
2009. In: Ann Oncol 20(Suppl 8): abs, 2009;
Progressi nel trattamento medico del carcinoma pancreatico. E. Vasile, S. Caponi, L. Ginocchi, M. Lucchesi, C.
Caparello, A. Falcone. Terapie Mediche Innovative in Oncologia, II Congresso del Gruppo Oncologico Chirurgico
Cooperativo Italiano (GOCCI), Firenze 6-9 Novembre 2009;
Prognostic relevance of lymph node metastases and adjuvant treatment for patients with invasive intraductal
papillary mucinous neoplasms (IPMNs) of the pancreas. S. Caponi, E. Vasile, M. Del Chiaro, N. Funel, L.
Ginocchi, M. Lucchesi, D. Campani, A. Falcone, U. Boggi, F. Mosca. Proceedings 2010 Gastrointestinal
Cancers Symposium (ASCO – GI), Orlando, Florida, January 22-24, 2010 120: 252;
Prognosis and chemotherapy sensitivity of metastatic biliary cancers according to primary tumor site. M.
Lucchesi, S. Caponi, D. Santini, S. Intagliata, L. Ginocchi, V. Virzì, E. Vasile, G. Tonini, A. Falcone. Proceedings
2010 Gastrointestinal Cancers Symposium (ASCO – GI), Orlando, Florida, January 22-24, 2010 127: 278;
Evaluation of prognostic factors and of the role of adjuvant chemotherapy in patients with invasive carcinoma
derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas. E. Vasile, S. Caponi, M.
Lucchesi, M. Del Chiaro, N. Funel, L. Ginocchi, D. Campani, A. Falcone, U. Boggi, F. Mosca. Proceedings 2010
Gastrointestinal Cancers Symposium (ASCO – GI), Orlando, Florida, January 22-24, 2010 J Clin Oncol 28(S):
abstr e14605, 2010;
Adjuvant gemcitabine-based chemoradiation compared to gemcitabine alone following radical surgical resection
for pancreatic ductal adenocarcinoma (PDAC): a retrospective analysis. C. Caparello, E. Vasile, F. Pasqualetti, A.
Sainato, M. Del Chiaro, M. Coppola, S. Caponi, N. Funel, C. Croce, L. Ginocchi, M. Lucchesi, D. Campani, F.
Mosca, U. Boggi, C. Greco, A. Falcone. Proceedings European Pancreatic Club (EPC) 2010, Stockholm, June
16-19, Pancreatology 2010; 10: 259-400;
Second-line combination chemotherapy in metastatic pancreatic cancer (MPC) patients after failure of a first-line
chemotherapeutic doublet. L. Ginocchi, E. Vasile, M. Lucchesi, S. Caponi, C. Caparello, A. Falcone.
Proceedings European Pancreatic Club (EPC) 2010, Stockholm, June 16-19, Pancreatology 2010; 10: 259-400;
Prognostic relevance of lymph node metastases and adjuvant treatment for patients with invasive intraductal
papillary mucinous neoplasms (IPMNs) of the pancreas. S. Caponi, E. Vasile, M. Del Chiaro, N. Funel, A.
Sainato, F. Pasqualetti, M. Coppola, L. Ginocchi, C. Caparello, M. Lucchesi, C. Croce, C. Greco, D. Campani, A.
Falcone, F. Mosca, U. Boggi. Proceedings European Pancreatic Club (EPC) 2010, Stockholm, June 16-19,
Pancreatology 2010; 10: 259-400;
Invasive carcinoma derived from intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: evaluation
of prognostic factors and of the role of djuvant chemotherapy. E. Vasile, L. Ginocchi, M. Lucchesi, S. Caponi, C.
Caparello, M, Del Chiaro, A. Sainato, N. Funel, F. Pasqualetti, C. Croce, C. Greco, D. Campani, U. Boggi, F.
Mosca, A. Falcone. Proceedings 12th World Congress on Gastrointestinal Cancer (ESMO Conference),
Barcelona, Spain, June 30 – July 3, 2010. In: Ann Oncol 21 (Suppl 6): abs P-0273, 2010;
Prognosis and chemosensitivity of metastatic biliary cancers according to primary tumor site. M. Lucchesi, D.
Santini, E. Vasile, S. Caponi, L. Ginocchi, C. Caparello, S. Intagliata, V. Virzì, G. Tonini, A. Falcone. Proceedings
12th World Congress on Gastrointestinal Cancer (ESMO Conference), Barcelona, Spain, June 30 – July 3, 2010.
In: Ann Oncol 21 (Suppl 6): abs P-0240, 2010;
Adjuvant chemotherapy for resected biliary tract cancer: a retrospective analysis. S. Caponi, M. Lucchesi, E.
Vasile, C. Caparello, L. Ginocchi, M. Lencioni, S. Ricci, A. Falcone. Proceedings 35th ESMO Congress Scientific
Committee, Milan, Italy, October 8-12, 2010. In: Ann Oncol, 21: viii262, 2010;
Adjuvant chemotherapy for radically resected biliary tract cancer: a retrospective analysis. M. Lucchesi, E.
Vasile, C. Caparello, S. Caponi, L. Ginocchi, M. Lencioni, S. Ricci, A. Falcone. Proceedings 12th National
Congress of Medical Oncology (AIOM), Rome, Italy, November 6-8, 2010. In: Tumori, 10: S142, 2010;
Natural history of invasive intraductal papillary mucinous neoplasms (IPMNs) of the pancreas compared with
sporadic pancreatic adenocarcinoma (PDAC). L. Ginocchi, S. Caponi, E. Vasile, M. Del Chiaro, N. Funel, A.
Sainato, F. Pasqualetti, M. Coppola, C. Caparello, M. Lucchesi, C. Croce, C. Greco, D. Campani, A. Falcone, F.
Mosca, U. Boggi. Proceedings 12th National Congress of Medical Oncology (AIOM), Rome, Italy, November 6- 8,
2010. In: Tumori, 10: S147 – S148, 2010;
Adjuvant gemcitabine-based chemoradiation compared to gemcitabine alone following radical surgical resection
for pancreatic ductal adenocarcinoma (PDAC): a retrospective analysis. C. Caparello, E. Vasile, F. Pasqualetti, A.
Sainato, M. Del Chiaro, M. Coppola, S. Caponi, N. Funel, C. Croce, L. Ginocchi, M. Lucchesi, D. Campani, F.
Mosca, U. Boggi, C. Greco, A. Falcone. Proceedings 12th National Congress of Medical Oncology (AIOM),
Rome, Italy, November 6-8, 2010. In: Tumori, 10: S149 – S150, 2010;
Third-line folfiri in metastatic gastric cancer patients. L. Ginocchi, C. Caparello, S. Caponi, M. Lucchesi, M.
Lencioni, E. Vasile, L. Fornaro, G. Masi, S. Ricci, A. Falcone. Proceedings 13th World Congress on
Gastrointestinal Cancer (ESMO), Barcelona, Spain, 22 – 25 June, 2011. In: Ann Oncol, 22: v41, 2011;
Retrospective analysis of second-line chemotherapy in biliary tract cancer. M. Lucchesi, E.Vasile, S. Caponi, L.
Ginocchi, C. Caparello, M. Lencioni, S. Ricci, A. Falcone. Proceedings 13th World Congress on Gastrointestinal
Cancer (ESMO), Barcelona, Spain, 22 – 25 June, 2011. In: Ann Oncol, 22: v81, 2011;
Adjuvant chemotherapy for resected biliary tract cancer: A retrospective analysis. M. Lucchesi, E. Vasile, M.
Lencioni, C. Caparello, S. Caponi, L. Ginocchi, U. Boggi, F. Mosca, F. Filipponi, M. Seccia, M. Chiarugi, M.
Andreuccetti, S. Ricci, A. Falcone. Proceedings 47th Annual Meeting American Society of Clinical Oncology
(ASCO), Chicago, Illinois, 3 – 7 June, 2011. In: J Clin Oncol 29, 2011;
Modified FOLFOXIRI in advanced pancreatic cancer. L. Ginocchi, E. Vasile, S. Caponi, M. Lucchesi, C.
Caparello, V. Da Prat, M. Baretti, M. Lencioni, S. Ricci, A. Falcone. Proceedings 37th ESMO Congress Scientific
Committee, Vienna, Austria, 28 September-2 October, 2012. In: Ann Oncol, 23: ix238, 2012;
Second-line docetaxel (D) in metastatic gastric cancer (MGC). C. Caparello, M. Lencioni, E. Vasile, S. Caponi, S.
Santi, M.G. Fabrini, L. Ginocchi, M. Lucchesi, S. Ricci, A. Falcone. 37th ESMO Congress Scientific Committee,
Vienna, Austria, 28 September-2 October, 2012. In: Ann Oncol, 23: ix251, 2012;
Third-line FOLFIRI in metastatic gastric cancer patients. C. Caparello, E. Vasile, M. Lencioni, M.G. Fabrini, M.
Lucchesi, L. Ginocchi, S. Caponi, S. Santi, S. Ricci, A. Falcone. 37th ESMO Congress Scientific Committee,
Vienna, Austria, 28 September-2 October, 2012. In: Ann Oncol, 23: ix251, 2012;
Lung progression after resection for invasive intraductal papillary mucinous neoplasms (IPMNs) of the pancreas.
S. Caponi, E. Vasile, M. Lucchesi, C. Caparello, L. Ginocchi, A. Falcone. XXXVI Annual Meeting of Italian
Association for the Study of the Pancreas (AISP), Italy, Bologna, 4-6 October 2012, Oral comunication. In: JOP. J
Pancreas 2012 Sep 20; 13 (5): 555;
Modified FOLFOXIRI in advanced Pancreatic Cancer. L. Ginocchi, E. Vasile, S. Caponi, M. Lucchesi, C.
Caparello, M. Lencioni, S. Ricci, A. Falcone. XXXVI Annual Meeting of Italian Association for the Study of the
Pancreas (AISP), Italy, Bologna, 4-6 October 2012, Oral comunication. In: JOP. J Pancreas 2012 Sep 20; 13 (5):
563;
Fixed-dose rate gemcitabine plus capecitabine as second-line treatment for metastatic pancreatic cancer patients
pretreated with oxaliplatin. C. Caparello, E. Vasile, M. Lucchesi, L. Ginocchi, S. Caponi, M. Lencioni, S. Ricci, A.
Falcone. XXXVI Annual Meeting of Italian Association for the Study of the Pancreas (AISP), Italy, Bologna, 4-6
October 2012. In: JOP. J Pancreas 2012 Sep 20; 13 (5): 563;
Chemotherapy for metastatic invasive Intraductal Papillary Mucinous Neoplasm (IPMNs) of the pancreas. M.
Lucchesi, E. Vasile, S. Caponi, L. Ginocchi, C. Caparello, A. Falcone. XXXVI Annual Meeting of Italian
Association for the Study of the Pancreas (AISP), Italy, Bologna, 4-6 October 2012. In: JOP. J Pancreas 2012
Sep 20; 13 (5): 563;
Phase II study of neoadjuvant modified FOLFOXIRI in locally advanced pancreatic cancer. E, vasile, N. De Lio,
C. Cappelli, L. Pollina, L. Ginocchi, A. Sainato, M. Lucchesi, N. Funel, C. Caparello, S. Caponi, V. Perrone, F.
Pasqualetti, S. Signori, S. Mazzeo, M. Belluomini, C. Greco, D. Campani, F. Mosca, A. Falcone, U. Boggi. XXXVI
Annual Meeting of Italian Association the Study of the Pancreas (AISP), Italy, Bologna, 4-6 October 2012. In:
JOP. J Pancreas 2012 Sep 20; 13 (5): 563;
Modified FOLFOXIRI in advanced pancreatic cancer. L. Ginocchi, E. Vasile, S. Caponi, M. Lucchesi, C.
Caparello, V. Da Prat, M. Baretti, M. Lencioni, S. Ricci, A. Falcone. Proceedings 14th National Congress of
Medical Oncology (AIOM), Rome, Italy, 27-29 October, 2012. In: Tumori, 13 (3): S12, 2012;
Phase II study of neoadjuvant modified FOLFOXIRI in locally advanced pancreatic cancer. E. Vasile, N. De Lio,
C. Caparello, L. Pollina, L. Ginocchi, A. Sainato, M. Lucchesi, N. Funel, C. Caparello, S. Caponi, V. Perrone, F.
Pasqualetti, S. Signori, S. Mazzeo, C. Greco, D. Campani, F. Mosca, A. Falcone, U. Boggi. Proceedings 14th
National Congress of Medical Oncology (AIOM), Rome, Italy, 27-29 October, 2012. In: Tumori, 13 (3): S12, 2012;
A retrospective analysis of HER-2, hyperexpression in gastric and gastroesophageal junction (GEJ). M. Lencioni,
E. Vasile, L. Ginocchi, L. Di Maso, C. Caparello, S. Caponi, M. Baretti, M. Lucchesi, V. Da Prat, L. Belluomini, S.
Ricci, A. Falcone, C. Ugolini, G. Fontanini, B. Solito, S. Santi, M.G. Fabrini. Proceedings 14th National Congress
of Medical Oncology (AIOM), Rome, Italy, 27-29 October, 2012. In: Tumori, 13 (3): S13, 2012;
FOLFIRI as third-line treatment in metastatic gastric cancer. S. Santi, C. Caparello, E. Vasile, M. Lencioni, S.
Caponi, L. Ginocchi, M. Lucchesi, L. Belluomini, M.G. Fabrini, V. Da Prat, M. Baretti, S. Ricci, A. Falcone.
Proceedings 14th National Congress of Medical Oncology (AIOM), Rome, Italy, 27-29 October, 2012. In: Tumori,
13 (3): S13, 2012;
Role of adjuvant chemotherapy in the treatment of radically resected biliary tract cancer: a single institution
experience. M. Lucchesi, E. Vasile, L. Ginocchi, S. Caponi, V. Da Prat, C. Caparello, M. Baretti, M. Lencioni, I.
Lombardi, S. Ricci, A. Falcone. Proceedings 14th National Congress of Medical Oncology (AIOM), Rome, Italy,
27-29 October, 2012. In: Tumori, 13 (3): S14, 2012;
Fixed-dose rate gemcitabine plus capecitabine: a second-line option for metastatic pancreatic cancer patients
pretreated with oxaliplatin. G. Masi, M. Lucchesi, C. Caparello, E. Vasile, L. Ginocchi, S. Caponi, V. Da Prat, M.
Baretti, M. Lencioni, S. Ricci, A. Falcone. Proceedings 14th National Congress of Medical Oncology (AIOM),
Rome, Italy, 27-29 October, 2012. In: Tumori, 13 (3): S15, 2012;
Optimal preoperative staging and early detection of lung metastases for patients affected by invasive Intraductal
Papillary Mucinous Neoplasm (IPMNs) of the pancreas. S. Caponi, E. Vasile, C. Caparello, L. Ginocchi, M.
Lucchesi, M. Baretti, V. Da Prat, M. Lencioni, S. Ricci, A. Falcone. Proceedings 14th National Congress of
Medical Oncology (AIOM), Rome, Italy, 27-29 October, 2012. In: Tumori, 13 (3): S17, 2012;
Docetaxel as second-line treatment in metastatic gastric cancer. C. Caparello, M. Lencioni, E. Vasile, S. Caponi,
M.G. Fabrini, L. Ginocchi, M. Lucchesi, M. Baretti, L. Belluomini, V. Da Prat, S. Santi, G. Pallabazzer, S. Ricci,
A. Falconi. Proceedings 14th National Congress of Medical Oncology (AIOM), Rome, Italy, 27-29 October, 2012.
In: Tumori, 13 (3): S17, 2012;
Chemotherapy for metastatic invasive Intraductal Papillary Mucinous Neoplasms (IPMNs) of the pancreas. S.
Ricci, S. Caponi, M. Baretti, E. Vasile, L. Ginocchi, C. Caparello, V. Da Prat, M. Lucchesi, M. Lencioni, A.
Falcone. Proceedings 14th National Congress of Medical Oncology (AIOM), Rome, Italy, 27-29 October, 2012.
In: Tumori, 13 (3): S19, 2012;
Phase II study of neoadjuvant chemotherapy with FOLFOXIRI in borderline resectable pancreatic cancer. S.
Caponi, E. Vasile, N. De Lio, C. Cappelli, L. Pollina, N. Funel, A. Sainato, L. Ginocchi, M. Lucchesi, C.
Caparello, M. Belluomini, V. Perrone, F. Pasqualetti, M. Lencioni, S. Signori, S. Mazzeo, C. Greco, D. Campani,
A. Falcone, F. Mosca, U. Boggi. Proceedings 15th National Congress of Medical Oncology (AIOM), Rome, Italy,
11-13 October, 2013. In: Tumori 2013; 14: S170 (abstr Q17);
Early integration of supportive care in cancer patients: the Pisa cancer center experience. A. Antonuzzo, E.
Vasile, I.M. Brunetti, L. Ginocchi, M. Lucchesi, L. Derosa, C. Cremolini, S. Caponi, L. Salvatore, E. Bona, L.
Galli, S. Ricci, A. Falcone. Proceedings 15th National Congress of Medical Oncology (AIOM), Rome, Italy, 11-13
October, 2013. In: Tumori 2013; 14: S53 (abstr E22);
Retrospective analysis of patients with cancer pain evaluated inside Pisa medical oncology consultation pain
therapy service. L. Ginocchi, I.M. Brunetti, A. Antonuzzo, E. Vasile, M. Lucchesi, L. Galli, C. Caparello,, C.
Vivaldi, I. Ferrarini, E. Biasco, A. Farnesi, R. Marconcini, F. Bondi, L. Tollapi, P. Poli, S. Ricci, A. Falcone.
Proceedings 15th National Congress of Medical Oncology (AIOM), Rome, Italy, 11-13 October, 2013. In: Tumori
2013; 14: S61 (abstr E41);
Biomolecular assessment in radically resected biliary tract cancer. M. Lucchesi, C. Lupi, A. Proietti, E. Sensi, C.
Ugolini, S. Caponi, M. Lencioni, L. Ginocchi, C. Caparello, A. Vivaldi, S. Ricci, F. Basolo, A. Falcone, G.
Fontanini, E. Vasile. Proceedings 15th National Congress of Medical Oncology (AIOM), Rome, Italy, 11-13
October, 2013. In: Tumori 2013; 14: S177 (abstr Q33);
Serum Ca 19.9 as a marker of survival in patient with borderline resectable pancreatic cancer treated with
neoadjuvant FOLFOXIRI. C. Caparello, E. Vasile, N. De Lio, C. Caparello, L. Pollina, N. Funel, A. Sainato, L.
Ginocchi, M. Lucchesi, S. Caponi, C, Vivaldi, M. Belluomini, V. Perrone, F. Pasqualetti, M. Lencioni, F. Caniglia,
S. Mazzeo, D. Campani, A. Falcone, F. Mosca, U. Boggi. Proceedings 15th National Congress of Medical
Oncology (AIOM), Rome, Italy, 11-13 October, 2013. In: Tumori 2013; 14: S178 (abstr Q35);
Recurrence after complete resection of gastrointestinal or pancreatic neuroendocrine tumors: Single institution
analysis. R. Marconcini, S. Ricci, L. Galli, A. Antonuzzo, L. Derosa, A. Farnesi, E. Biasco, E. Vasile, M.
Lucchesi, A. Falcone. 38th ESMO Congress Scientific Committee, Amsterdam, Netherlands, 27 September-1
October, 2013. In: Ann Oncol, abstr 2544, 2013;
A new model of early supportive care and symptoms management: The experience of Pisa medical oncology. A.
Antonuzzo, E. Vasile, M. Lucchesi, L. Ginocchi, L. Galli, I.M. Brunetti, S. Ricci, A. Falcone. Proceedings 49th
ASCO Annual Meeting 2013, Chicago, Illinois , May 31-June 4, 2013. J Clin Oncol 31, 2013 (suppl; abstr
e20711);
Phase II study of neoadjuvant chemotherapy with modified FOLFOXIRI in bordenline resectable or unresectable
stage III pancreatic cancer. E. Vasile, N. De Lio, C. Cappelli, L. Pollina, N. Funel, A. Sainato, L. Ginocchi, M.
Lucchesi, C. Caparello, S. Caponi, V. Perrone, F. Pasqualetti, F. Caniglia, S. Signori, S. Mazzeo, C. Greco, A.
Falcone, F. Mosca, U. Boggi. . Proceedings 49th ASCO Annual Meeting 2013, Chicago, Illinois , May 31-June 4,
2013. J Clin Oncol 31, 2013 (suppl; abstr 4062);
Supportive care and symptoms management in Pisa medical oncology. A. Antonuzzo, L. Ginocchi, E. Vasile, M.
Lucchesi, I. Brunetti, L. Galli, S. Ricci, A. Falcone. 2013 MASCC/ISOO International Symposium on Supportive
Care In Cancer Berlin, Germany, June 27-29, 2013. In: Support Care Cancer (2013) 21 (Suppl 1):S1–S301, abstr
0651. DOI 10.1007/s00520-013-1798-3;
A retrospective analysis of HER-2 hyperexpression in gastric and gastroesophageal junction (GEJ). C. Caparello,
M. Lencioni, L. Ginocchi, E. Vasile, S. Caponi, C. Vivaldi, A. Gonnelli, L. Belluomini, M. Lucchesi, C. Ugolini, G.
Fontanini, S. Santi, S. Ricci, A. Falcone. 10th International Gastric Cancer Congress (IGCC) 2013; P30-16;
Docetaxel as second-line treatment in metastatic gastric cancer. M. Lencioni, C. Caparello, E. Vasile, L. Ginocchi,
S. Caponi, M. Lucchesi, L. Belluomini, A. Gonnelli, C. Vivaldi, S. Santi, S. Ricci, A. Falcone. 10th International
Gastric Cancer Congress (IGCC) 2013; P46-12;
FOLFIRI as third-line chemotherapu in metastatic gastric cancer. L. Ginocchi, M. Lencioni, C. Caparello, S. Santi,
E. Vasile, S. Caponi, C. Vivaldi, M. Lucchesi, L. Belluomini, A. Gonnelli, M.G. Fabrini, S. Ricci, A. Falcone. 10th
International Gastric Cancer Congress (IGCC) 2013; P46-15;
The economic costs of symptom management and toxicities in cancer patients treated in ambulatory setting. L.
Ginocchi, A. Pasdera, E. Vasile, M. Lucchesi, I.M. Brunetti, S. Ricci, A. Falcone. A. Antonuzzo. Multinational
Association of Supportive Care in Cancer (MASCC), Miami, USA, June 26-28, 2014. Supportive Care in Cancer
(2014) 22 (Suppl 1): S1-S238, abstr 0595. DOI 10.1007/s00520-014-2222-3;
Supportive care in cancer patients: report of activity. M. Lucchesi, E. Vasile, L. Ginocchi, I.M. Brunetti, S. Ricci,
A. Falcone, A. Antonuzzo. Multinational Association of Supportive Care in Cancer (MASCC), Miami, USA, June
26-28, 2014. Supportive Care in Cancer (2014) 22 (Suppl 1): S1-S238, abstr 0594. DOI 10.1007/s00520-0142222-3;
Supportive care activity and reduction of hospitalizations for cancer patients. E. Vasile, M. Lucchesi, I.M.
Brunetti, L. Ginocchi, S. Ricci, A. Falcone, A. Antonuzzo. Multinational Association of Supportive Care in Cancer
(MASCC), Miami, USA, June 26-28, 2014. Supportive Care in Cancer (2014) 22 (Suppl 1): S1-S238, abstr 0593.
DOI 10.1007/s00520-014-2222-3;
Patients’ reported outcome about a supportive care service. I.M. Brunetti, E. Vasile, L. Ginocchi, M. Lucchesi, S.
Ricci, A. Falcone, A. Antonuzzo. Multinational Association of Supportive Care in Cancer (MASCC), Miami, USA,
June 26-28, 2014. Supportive Care in Cancer (2014) 22 (Suppl 1): S1-S238, abstr 0600. DOI 10.1007/s00520014-2222-3.
Her-2 overexpression has a negative prognostic role in biliary tract cancer. Vivaldi C., Ugolini C., Lucchesi M.,
Lupi C., Proietti A., Sensi E., Caponi S., Lencioni M., Ginocchi L., Caparello C., Musettini G., Niccoli C., Masi G.,
Ricci S., Campani D., Basolo F., Falcone A., Fontanini G., Vasile E. In: Tumori 2014; 15(S): abstr B22.
Cancer pain: a retrospective analysis of patients evaluated inside pisa medical oncology supportive care room.
Ginocchi L., Brunetti I.M., Vasile E., Antonuzzo A., Bondi F., Tollapi L., Lucchesi M., Gonnelli A., Belluomini L.,
Poli P., Ricci S., Falcone A. Proceedings 16th National Congress of Medical Oncology (AIOM), Rome, Italy. In:
Tumori 2014; 15(S): abstr F31.
Pharmacological modulation of blood-brainbarrier: a novel therapeutic approach to refractory cns tumor. Sabrina
Becciani, Martina Da Ros, Anna Lisa Iorio, Laura Giunti, Alessia Stival, Maurizio Lucchesi, Maura Massimino,
Maurizio de Martino, and Iacopo Sardi. 3rd Biennial Conference on Pediatric Neuro-Oncology Basic and
Translational Research, San Diego, California. In: Neuro-Oncology 2015; 17 (S): abstr TR-03
Pediatric anaplastic meningioma: a case report successfully treated with combined chemotherapy for soft tissue
sarcomas and radiotherapy. Maurizio Lucchesi, Sabrina Becciani, Anna Maria Buccoliero, Alessia Stival,
Ludovica Facchini, Silvia Farina, Maurizio de Martino, and Iacopo Sardi. 3rd Biennial Conference on Pediatric
Neuro-Oncology Basic and Translational Research, San Diego, California. In: Neuro-Oncology 2015; 17 (S):
abstr OT-02.
RELAZIONI CONGRESSUALI
Il presente CV è composto di 10 pagine.
Firenze, 28/05/2015
In fede,